InvestorsHub Logo
Followers 91
Posts 1956
Boards Moderated 0
Alias Born 07/31/2013

Re: None

Thursday, 04/10/2014 8:31:53 AM

Thursday, April 10, 2014 8:31:53 AM

Post# of 148750
DCTH Delcath $3.60's
Struggled since FDA rejection. Probably worth $3.60 (post R/S). But short term would expect to bleed as a result of sentiment.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.